← FDA Drug Approvals (Drugs@FDA)
TRIFLURIDINE; TIPIRACIL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INTAS PHARMS LTD · Approved 2022-10-13
Drug application
- FDA Application #
ANDA214036- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TRIFLURIDINE; TIPIRACIL
- Generic name
- Trifluridine
- Active ingredients
- TRIFLURIDINE; TIPIRACIL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- INTAS PHARMS LTD
- First approval
- 2022-10-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown